Salvo Health Raises $5M in Seed Prime Funding

Salvo Health, a NYC-based healthcare technology company, raised $5M in Seed Prime funding.

The round was led by City Light Capital and Human Ventures, with participation from Threshold Ventures, Torch Capital, and Felicis Ventures, as well as angel investors such as Anmol Madan. Salvo also announced thatĀ Rachel ParlierĀ of City Light andĀ Emily MeltonĀ of Threshold will join the Board of Directors, alongside Jeffrey Glueck, the Founder & CEO of Salvo.

The company intends to use the funds to expand deployment of its wraparound GI care at providers including gastroenterology private practices, health systems, and ACOs.

Salvo focuses on enabling local providers across the country to provide ā€œwraparound careā€ for chronic GI and metabolic liver conditions in a hybrid approach. Patients remain under the care of their local physician, adding Salvo telehealth and app-based daily support for follow-on care. It helps solve staff shortages and clinician burnout by enabling insurance-covered, evidence-based, interdisciplinary care including its teams of licensed nurses, registered dietitians, and health specialists.Ā 

Salvo enables providers to billĀ RPM and CCMĀ codes for both Medicare and commercial patients where such codes are broadly covered, thereby improving patient outcomes and generating new ancillary service revenue for practices. This positions large practices and systems on the path to value-based care arrangements, including shared savings and quality incentives. The model also frees providers to see more acute cases and more new patients by enabling patients to access daily support from their team at Salvo.

Glueck, who launched Salvo in 2021, formerly served as CEO of Foursquare and as product leader and Chief Marketing Officer at Travelocity.